Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Industry / Manufacturing/  Stada strikes oncology deal with Hetero Drugs
BackBack

Stada strikes oncology deal with Hetero Drugs

Stada to get exclusive marketing rights in Europe for generic oncology drugs developed and produced by Hetero

The alliance covers cancer drugs that will lose patent protection between 2016 and 2020. Photo: MintPremium
The alliance covers cancer drugs that will lose patent protection between 2016 and 2020. Photo: Mint

Frankfurt: German generic drug maker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday.

As part of the agreement in principle, with details yet to be hammered out, Stada will get exclusive marketing rights in Europe for generic oncology drugs developed and produced by Hetero. Stada will also get a sub-licence in further regions outside India and the United States.

The alliance covers cancer drugs that will lose patent protection between 2016 and 2020 and Stada will decide at a later stage whether Hetero compounds will also go its existing oncology drugs, Stada chief executive Hartmut Retzlaff said at a press conference.

Financial terms were not provided.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 26 Mar 2015, 11:54 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹557.550.52%
ITC
₹4280.13%
₹2,987.85-0.37%
₹152.852%
Switch to the Mint app for fast and personalized news - Get App